Patrys Ltd has released a press release.
PAT-DX1 Improves Survival in Animal Model of Glioblastoma
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Patrys
- PAT-DX1 Crosses Blood Brain Barrier to Reduce Tumour Size
- Appendix 4D - Half Year Accounts - 31 December 2017
- Appendix 4C - Quarterly - 31 December 2017
- Publication and Patent Filing for Humanized Version of 3E10
- PAT-DX1-NP Localizes to Lymph Node Metastases
Later from Patrys
- Appendix 4C - Quarterly - 31 March 2018
- Patrys Completes $3.5M Placement
- New Pre-Clinical Collaboration on PAT-DX1
- Patrys Increases Capital Raising to $4.6 million
- PAT-DX1 Targets and Kills Brain Cancer Stem Cells
Follow Patrys into a list and get an email when it puts out news.
Follow Patrys